Choosing an ideal pharmacotherapeutic strategy for dyslipidemia in children.

Dyslipdiemia can manifest at a young age, and it is a risk factor for atherosclerotic cardiovascular disease (ASCVD), the principal cause of mortality in developed nations. Therefore, treating it a...